Venous thromboembolism in critical illness in a community intensive care unit☆☆☆★
To access this article, please choose from the options below
☆ Data collection was conducted at Hotel-Dieu Grace Hospital, Windsor, Ontario, Canada. Data analysis and manuscript preparation performed at Queen's University, Kingston, Canada, and McMaster University, Hamilton, Canada.
☆☆ This study was supported by the Physician's Services Incorporated Foundation of Ontario, Ontario, Canada.
★ J Muscedere and D Cook received study medication from Pfizer, Inc (Kirkland, Quebec, Canada) for use in a peer-review funded randomized trial testing heparin thromboprophylaxis. D. Cook received an arm's-length grant-in-aid from Pfizer, Inc for an unrelated observational study on thromboprophylaxis. D. Heyland has no conflicts to disclose.
PII: S0883-9441(07)00040-8
doi:10.1016/j.jcrc.2007.02.003
© 2007 Elsevier Inc. All rights reserved.
